孤独症谱系障碍的症状前检测与干预
文章指出,尽管建议在出生后前2年进行普遍筛查,但许多患儿仍被漏诊并延迟诊断。研究正在评估婴儿期症状出现前的客观风险检测(如MRI筛查高风险婴儿),但尚未开展临床试验。本文提出一项结合症状前检测与干预的假设性临床试验设计,并通过多视角评论探讨伦理问题。
要点
- 婴儿期MRI筛查高风险家族史婴儿有前景但未经临床试验验证。
- 症状前检测与干预的临床试验设计需提前考虑伦理问题。
- 多视角评论涵盖社会价值、临床挑战、神经多样性及风险获益。
核心结论
- 症状前检测与干预的临床试验需在开展前充分评估伦理问题。
研究设计与样本
- 本文提出一项结合症状前检测与干预的假设性临床试验设计。
主要发现
- 针对高风险家族史婴儿的MRI筛查初步研究显示前景,但尚未在临床试验中评估。
临床怎么用
- 临床医生应了解症状前检测的研究进展及相关的伦理考量。
局限性
- 本文为假设性试验设计,未报告实际试验数据或结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Universal screening for autism spectrum disorder (ASD) is recommended during pediatric primary care visits in the first 2 years of life. However, many children are missed by initial screening and not diagnosed with ASD until years later. Research efforts are underway to develop and evaluate new objective measures of risk for ASD that can be used in infancy, before symptoms emerge. Initial studies with these tests, particularly MRI-based screening for infants at high familial risk, have shown promise but have not yet been evaluated in clinical trials. We present the study design for a hypothetical clinical trial that would combine presymptomatic detection and intervention for ASD and consider, through commentaries from diverse perspectives, the ethical issues that should be anticipated in advance of beginning such trials. Commentators Drs Pruett and Piven address the social value of the proposed research and importance of researcher-bioethicist collaborations. Drs Estes and Wolff discuss the clinical potential and challenges of developing presymptomatic interventions for infants at risk for ASD. Dr Harrington takes a neurodiversity view of presymptomatic prediction and intervention and their implications for autistic identity and quality of life. Finally, Drs MacDuffie, Peay and Wilfond consider the potential risks and benefits that must be evaluated and weighed in the next phases of research on presymptomatic detection and intervention for ASD.
引用
- MacDuffie KE, Estes AM, Harrington LT, et al. Presymptomatic Detection and Intervention for Autism Spectrum Disorder. Pediatrics. 2021. PMID: 33853890. doi:10.1542/peds.2020-032250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。